semaglutide 日本 High Rates of Discontinuation Among Older Adults with Diabetes in the US and Japan PDF) Japan initiates market authorization

Semaglutide GLP-1 injections offer a highly effective weight loss solution, helping patients reduce appetite, control cravings, and achieve sustainable weight loss

April 12, 2023

Medical professionals must thoroughly evaluate patients, balancing the benefits and risks of using semaglutide for breastfeeding mothers

While compounded medications follow strict quality standards, they do not undergo FDA pre-market approval

The US Food and Drug Administration approved Wegovy for chronic weight management for people with a body mass index of 30 or more, or 27 or more for people with a weight-related condition like high blood pressure